Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Javier C Angulo

Showing results (91-100 of 127) with videos related to

Pageof 13
Sort By:
European Urology|November 28, 2012
Efficacy and tolerability of mirabegron, a β(3)-adrenoceptor agonist, in patients with overactive bladder: results from a randomised European-Australian phase 3 trialVik Khullar, Gerard Amarenco, Javier C Angulo, et al.
Neurourology and Urodynamics|September 7, 2022
Effect of LHRH analogs on lower urinary tract symptoms associated with advanced prostate cancer in real clinical practice: ANALUTS studyJuan Morote, Antonio Gómez-Caamaño, Raúl Poza de Celis, et al.
The Prostate|June 26, 2014
A DNA hypermethylation profile reveals new potential biomarkers for prostate cancer diagnosis and prognosisNadia Ashour, Javier C Angulo, Guillermo Andrés, et al.
NPJ Precision Oncology|April 18, 2019
Precise definition of PTEN C-terminal epitopes and its implications in clinical oncologyJanire Mingo, Sandra Luna, Ayman Gaafar, et al.
World Journal of Urology|January 17, 2019
Patient satisfaction with adjustable transobturator male system in the Iberian multicenter studyJavier C Angulo, Ignacio Arance, Antonio Ojea, et al.
Cancers|February 10, 2021
Soluble PD-L1 Is an Independent Prognostic Factor in Clear Cell Renal Cell CarcinomaGorka Larrinaga, Jon Danel Solano-Iturri, Peio Errarte, et al.
Cancers|March 29, 2023
Impact of the COVID-19 Pandemic on Cancer Diagnosis in Madrid (Spain) Based on the RTMAD Tumor Registry (2019-2021)Gregorio Garrido-Cantero, Federico Longo, Javier Hernández-González, et al.
Cancers|November 27, 2021
(Pro)renin Receptor Is a Novel Independent Prognostic Marker in Invasive Urothelial Carcinoma of the BladderGorka Larrinaga, Julio Calvete-Candenas, Jon Danel Solano-Iturri, et al.
Journal of Clinical Medicine|August 29, 2024
Results of Adjustable Trans-Obturator Male System for Stress Urinary Incontinence after Transurethral Resection or Holmium Laser Enucleation of the Prostate: International Multicenter StudyCarlos Téllez, Rodrigo Diego, Juliusz Szczesniewski, et al.
Journal of Clinical Medicine|January 11, 2022
ATOMS (Adjustable Transobturator Male System) Is an Effective and Safe Second-Line Treatment Option for Recurrent Urinary Incontinence after Implantation of an AdVance/AdVance XP Fixed Male Sling? A Multicenter Cohort AnalysisFabian Queissert, Keith Rourke, Sandra Schönburg, et al.
Pageof 13

Showing results (91-100 of 127) with videos related to

Sort By:
Pageof 13
European Urology|November 28, 2012
Efficacy and tolerability of mirabegron, a β(3)-adrenoceptor agonist, in patients with overactive bladder: results from a randomised European-Australian phase 3 trialVik Khullar, Gerard Amarenco, Javier C Angulo, et al.
Neurourology and Urodynamics|September 7, 2022
Effect of LHRH analogs on lower urinary tract symptoms associated with advanced prostate cancer in real clinical practice: ANALUTS studyJuan Morote, Antonio Gómez-Caamaño, Raúl Poza de Celis, et al.
The Prostate|June 26, 2014
A DNA hypermethylation profile reveals new potential biomarkers for prostate cancer diagnosis and prognosisNadia Ashour, Javier C Angulo, Guillermo Andrés, et al.
NPJ Precision Oncology|April 18, 2019
Precise definition of PTEN C-terminal epitopes and its implications in clinical oncologyJanire Mingo, Sandra Luna, Ayman Gaafar, et al.
World Journal of Urology|January 17, 2019
Patient satisfaction with adjustable transobturator male system in the Iberian multicenter studyJavier C Angulo, Ignacio Arance, Antonio Ojea, et al.
Cancers|February 10, 2021
Soluble PD-L1 Is an Independent Prognostic Factor in Clear Cell Renal Cell CarcinomaGorka Larrinaga, Jon Danel Solano-Iturri, Peio Errarte, et al.
Cancers|March 29, 2023
Impact of the COVID-19 Pandemic on Cancer Diagnosis in Madrid (Spain) Based on the RTMAD Tumor Registry (2019-2021)Gregorio Garrido-Cantero, Federico Longo, Javier Hernández-González, et al.
Cancers|November 27, 2021
(Pro)renin Receptor Is a Novel Independent Prognostic Marker in Invasive Urothelial Carcinoma of the BladderGorka Larrinaga, Julio Calvete-Candenas, Jon Danel Solano-Iturri, et al.
Journal of Clinical Medicine|August 29, 2024
Results of Adjustable Trans-Obturator Male System for Stress Urinary Incontinence after Transurethral Resection or Holmium Laser Enucleation of the Prostate: International Multicenter StudyCarlos Téllez, Rodrigo Diego, Juliusz Szczesniewski, et al.
Journal of Clinical Medicine|January 11, 2022
ATOMS (Adjustable Transobturator Male System) Is an Effective and Safe Second-Line Treatment Option for Recurrent Urinary Incontinence after Implantation of an AdVance/AdVance XP Fixed Male Sling? A Multicenter Cohort AnalysisFabian Queissert, Keith Rourke, Sandra Schönburg, et al.
Pageof 13